Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2021-06-04 | 2021-06-21 | 140428 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2021-07-16 | 2021-08-31 | 142687 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2022-07-05 | 2022-10-31 | 164083 |
| APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2022-07-29 | 2022-10-31 | 165674 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2022-07-29 | 2022-12-17 | 165677 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-05-19 | 2023-08-04 | 192803 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-05-19 | 2023-08-04 | 192821 |
| APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2023-07-13 | 2023-08-18 | 198480 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2023-07-13 | 2023-08-04 | 198486 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2023-07-13 | 2023-08-04 | 198489 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-09-22 | 2023-12-01 | 205002 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2023-11-10 | 2024-04-26 | 209957 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-12-22 | 2024-05-03 | 214247 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2024-03-01 | 2024-04-26 | 221090 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2024-03-27 | 2024-05-03 | 223543 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2024-09-27 | 2025-02-21 | 238841 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2024-10-10 | 2025-02-14 | 239819 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2024-10-18 | 2025-02-14 | 240627 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2024-10-24 | 2025-02-21 | 241072 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2024-11-07 | 2025-02-21 | 242214 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |